Correlation Between Morningstar Unconstrained and Marinus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Morningstar Unconstrained and Marinus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morningstar Unconstrained and Marinus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morningstar Unconstrained Allocation and Marinus Pharmaceuticals, you can compare the effects of market volatilities on Morningstar Unconstrained and Marinus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morningstar Unconstrained with a short position of Marinus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morningstar Unconstrained and Marinus Pharmaceuticals.

Diversification Opportunities for Morningstar Unconstrained and Marinus Pharmaceuticals

0.83

Correlation Coefficient

Morningstar Unconstrained  Marinus Pharmaceuticals

Very poor diversification

The 3 months correlation between Morningstar and Marinus is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Morningstar Unconstrained Allo and Marinus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marinus Pharmaceuticals and Morningstar Unconstrained is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morningstar Unconstrained Allocation are associated (or correlated) with Marinus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marinus Pharmaceuticals has no effect on the direction of Morningstar Unconstrained i.e., Morningstar Unconstrained and Marinus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Morningstar Unconstrained and Marinus Pharmaceuticals

Assuming the 90 days horizon Morningstar Unconstrained is expected to generate 6.39 times less return on investment than Marinus Pharmaceuticals. But when comparing it to its historical volatility, Morningstar Unconstrained Allocation is 6.49 times less risky than Marinus Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. Marinus Pharmaceuticals is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  140.00  in Marinus Pharmaceuticals on July 1, 2024 and sell it today you would earn a total of  44.00  from holding Marinus Pharmaceuticals or generate 31.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Morningstar Unconstrained Allo  vs.  Marinus Pharmaceuticals

Morningstar Unconstrained

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Morningstar Unconstrained Allocation are ranked lower than 14 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Morningstar Unconstrained may actually be approaching a critical reversion point that can send shares even higher in October 2024.

Marinus Pharmaceuticals

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Marinus Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Marinus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Morningstar Unconstrained and Marinus Pharmaceuticals

The main advantage of trading using opposite Morningstar Unconstrained and Marinus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morningstar Unconstrained position performs unexpectedly, Marinus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marinus Pharmaceuticals will offset losses from the drop in Marinus Pharmaceuticals' long position.

The idea behind Morningstar Unconstrained Allocation and Marinus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.